Literature DB >> 11221608

Absence of cardiac toxicity of zidovudine in infants.

W Lewis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11221608      PMCID: PMC4280909          DOI: 10.1056/NEJM200102083440613

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

1.  HIV nucleoside analogues: new adverse effects on mitochondria?

Authors:  A A Morris; A Carr
Journal:  Lancet       Date:  1999-09-25       Impact factor: 79.321

2.  Transplacental pharmacokinetics and fetal distribution of azidothymidine, its glucuronide, and phosphorylated metabolites in late-term rhesus macaques after maternal infusion.

Authors:  T A Patterson; Z K Binienda; G W Lipe; M P Gillam; W Slikker; J A Sandberg
Journal:  Drug Metab Dispos       Date:  1997-04       Impact factor: 3.922

3.  Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.

Authors:  S Blanche; M Tardieu; P Rustin; A Slama; B Barret; G Firtion; N Ciraru-Vigneron; C Lacroix; C Rouzioux; L Mandelbrot; I Desguerre; A Rötig; M J Mayaux; J F Delfraissy
Journal:  Lancet       Date:  1999-09-25       Impact factor: 79.321

Review 4.  Clinical approach to genetic cardiomyopathy in children.

Authors:  M L Schwartz; G F Cox; A E Lin; M S Korson; A Perez-Atayde; R V Lacro; S E Lipshultz
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

5.  Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.

Authors:  S E Lipshultz; K A Easley; E J Orav; S Kaplan; T J Starc; J T Bricker; W W Lai; D S Moodie; K McIntosh; M D Schluchter; S D Colan
Journal:  Circulation       Date:  1998-04-07       Impact factor: 29.690

6.  Zidovudine therapy and left ventricular function and mass in human immunodeficiency virus-infected patients.

Authors:  J S Cardoso; B Moura; A Mota-Miranda; F R Gonçalves; H Lecour
Journal:  Cardiology       Date:  1997 Jan-Feb       Impact factor: 1.869

7.  The pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus (P2C2 HIV) infection study: design and methods. The P2C2 HIV Study Group.

Authors: 
Journal:  J Clin Epidemiol       Date:  1996-11       Impact factor: 6.437

8.  Cardiac complications in children with human immunodeficiency virus infection. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group, National Heart, Lung, and Blood Institute.

Authors:  T J Starc; S E Lipshultz; S Kaplan; K A Easley; J T Bricker; S D Colan; W W Lai; W M Gersony; G Sopko; D S Moodie; M D Schluchter
Journal:  Pediatrics       Date:  1999-08       Impact factor: 7.124

9.  Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.

Authors:  S E Lipshultz; K A Easley; E J Orav; S Kaplan; T J Starc; J T Bricker; W W Lai; D S Moodie; G Sopko; S D Colan
Journal:  Circulation       Date:  2000-09-26       Impact factor: 29.690

10.  Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus.

Authors:  M J Domanski; M M Sloas; D A Follmann; P P Scalise; E E Tucker; D Egan; P A Pizzo
Journal:  J Pediatr       Date:  1995-07       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.